Sharechat Logo

Hanover investors learn their options

Thursday 20th November 2008

Text too small?
The proposal is being called a debt restructuring plan (DRP), rather than a moratorium.

Principal repayment is likely to be on a five-year timetable.

Details for the DRP will be live on www.depositrates.co.nz at 11 am. (Click here if you would like an email when the story is live).

The DRP will cover 14,000 debenture holders in Hanover Finance and United Finance, and the 1500 people who invested around $25 million in Hanover Capital notes and bonds.

It is expected that the company will aim to return 100% of debenture holders’ principal over a five year period.

However, bond and noteholders are only likely to get 50c in the $1 back.

As previously reported on www.depositrates.co.nz the shareholders, Mark Hotchin and Eric Watson, will stump up with cash and also the assets of Hanover’s property arm, Axis. These property assets will be transferred to the company at a discounted price.

It is expected, as reported earlier, that the support package will total up to $96 million made up of cash, assets and guarantees.

Investors have around $65 million invested in United Finance and $462 million in Hanover Finance.

Hotchin has previously said that one of the aims, aside from repaying investors, is to have a functioning company at the end of the DRP period in 2013.

Investors will get to vote on the proposal on December 9 in Auckland.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors